Leveraging crowdsourcing to facilitate the discovery of new medicines.

@article{Norman2011LeveragingCT,
  title={Leveraging crowdsourcing to facilitate the discovery of new medicines.},
  author={Thea C Norman and Chas Bountra and Aled M. Edwards and Keith R. Yamamoto and Stephen H. Friend},
  journal={Science translational medicine},
  year={2011},
  volume={3 88},
  pages={88mr1}
}
Gloomy predictions about the future of pharma have forced the industry to investigate alternative models of drug discovery. Public-private partnerships (PPPs) have the potential to revitalize the discovery and development of first-in-class therapeutics. The new PPP Arch2POCM hopes to foster biomedical innovation through precompetitive validation of pioneer therapeutic targets for human diseases. In this meeting report, we capture insights garnered from the April 2011 Arch2POCM conference. 
Related Discussions
This paper has been referenced on Twitter 13 times. VIEW TWEETS

From This Paper

Figures, tables, and topics from this paper.

Explore Further: Topics Discussed in This Paper

Citations

Publications citing this paper.
Showing 1-10 of 34 extracted citations

Open source drug discovery – A limited tutorial

Parasitology • 2014
View 1 Excerpt
Highly Influenced

E-learning paradigms: A model to address known issues

2017 Computing Conference • 2017
View 1 Excerpt

An agent-based approach for crowdsourcing software design

2016 Chinese Control and Decision Conference (CCDC) • 2016

References

Publications referenced by this paper.
Showing 1-10 of 13 references

Drug price increases come as companies peer over patent cliff,

J. D. Rockoff
Wall Street Journal, • 2011

Hit by the infamous patent cliff , big pharma strategize counter measures for the future

K. Megget
GlobalData Reports , 6 May • 2011

Leveraging crowdsourcing to facilitate the discovery of new medicines

T. C. Norman, C. Bountra, A. M. Edwards, K. R. Yamamoto, S. H. Friend
Competing interests: T.C.N. is an employee of Ambrx Inc., La Jolla, CA. Submitted • 2011

Levitch, High-level review of the business model, paper presented at the Arch2POCM Meeting

A. S. Friend
San Francisco, • 2011

Pharma growth expected to slow,

K. Megget
Online Pharma Times, • 2011

Reflections on the Innovative Medicines Initiative

M. Goldman
Nat. Rev. Drug Discov. 10, • 2011

Time to move the yardsticks

T. Norman, A. Edwards, C. Bountra, S. Friend, The precompetitive space
Sci. Transl. Med. 3, 76cm10 • 2011

Similar Papers

Loading similar papers…